Market Overview

Senesco Announces LOI to Merge with Fabrus

Senesco Technologies (OTC: SNTI) today announced that it has agreed to terms and executed a non-binding
Letter of Intent to merge with Fabrus, Inc (“Fabrus”), a privately-held,

Senesco Technologies (OTC: SNTI) today announced that it has agreed to terms and executed a non-binding
Letter of Intent to merge with Fabrus, Inc (“Fabrus”), a privately-held,
biotechnology company focused on expanding the clinical impact of
antibodies by addressing drug targets resistant to traditional antibody
discovery methods. Fabrus is committed to developing highly innovative
treatments to impact multiple diseases. Its research and technology is
published in the highly respected scientific journals Nature
Biotechnology and Cell.

See full press release

Posted-In: News Guidance Financing Contracts Management M&A Global

 

Most Popular

Related Articles (SNTI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free